Emerging delivery approaches for targeted pulmonary fibrosis treatment
Advanced Drug Delivery Reviews · 2024-01 · 204 · 115147
DOI: 10.1016/j.addr.2023.115147 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2024-01. Verfasst von Rimpy Diwan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas El Paso, El Paso, TX 79902, United States; Department of Biomedica…. Hauptthemen laut MEDLINE: Pulmonary Fibrosis. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 542 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, National Institutes of Health, Cancer Prevention and Research Institute of Texas.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas El Paso, El Paso, TX 79902, United States; Department of Biomedical Engineering, College of Engineering, The University of Texas El Paso…
Förderung
- NIH HHS
- National Institutes of Health
- Cancer Prevention and Research Institute of Texas
Zitieren
APA
Diwan, R., Bhatt, H. N., Beaven, E., & Nurunnabi, M. (2024). Emerging delivery approaches for targeted pulmonary fibrosis treatment. Advanced Drug Delivery Reviews, 204, 115147. https://doi.org/10.1016/j.addr.2023.115147
Vancouver
Diwan R, Bhatt HN, Beaven E, Nurunnabi M. Emerging delivery approaches for targeted pulmonary fibrosis treatment. Advanced Drug Delivery Reviews. 2024;204:115147. doi:10.1016/j.addr.2023.115147
BibTeX
@article{Diwan2024,
author = {Diwan, Rimpy and Bhatt, Himanshu N and Beaven, Elfa and Nurunnabi, Md},
title = {Emerging delivery approaches for targeted pulmonary fibrosis treatment},
journal = {Advanced Drug Delivery Reviews},
year = {2024},
volume = {204},
pages = {115147},
doi = {10.1016/j.addr.2023.115147}
}
EUVIMED